Erming Tian

5.4k total citations · 2 hit papers
64 papers, 3.8k citations indexed

About

Erming Tian is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Erming Tian has authored 64 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Hematology, 40 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Erming Tian's work include Multiple Myeloma Research and Treatments (48 papers), Glycosylation and Glycoproteins Research (13 papers) and Protein Degradation and Inhibitors (12 papers). Erming Tian is often cited by papers focused on Multiple Myeloma Research and Treatments (48 papers), Glycosylation and Glycoproteins Research (13 papers) and Protein Degradation and Inhibitors (12 papers). Erming Tian collaborates with scholars based in United States, Norway and Italy. Erming Tian's co-authors include John D. Shaughnessy, Bart Barlogie, Fenghuang Zhan, Ronald C. Walker, Yupo Ma, Erik Rasmussen, Jeffrey R. Sawyer, Guido Tricot, Klaus Bumm and Maurizio Zangari and has published in prestigious journals such as New England Journal of Medicine, Blood and PLoS ONE.

In The Last Decade

Erming Tian

62 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Role of the Wnt-Signaling Antagonist DKK1 in the Development of Osteolytic Lesions in Multiple Myeloma

2003 1.1k citations Erming Tian, Fenghuang Zhan et al. New England Journal of Medicine profile →
Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells

2002 507 citations Fenghuang Zhan, Erming Tian et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erming Tian United States	25	2.4k	1.9k	1.5k	361	351	64	3.8k
Shmuel Yaccoby United States	38	3.0k 1.2×	3.7k 1.9×	3.0k 2.0×	537 1.5×	522 1.5×	112	5.5k
Yazan Alsayed United States	29	2.2k 0.9×	1.9k 1.0×	1.5k 1.0×	529 1.5×	309 0.9×	61	3.1k
George Mulligan United States	28	4.0k 1.7×	1.5k 0.8×	2.4k 1.6×	253 0.7×	224 0.6×	51	4.9k
Klaus H. Metzeler Germany	29	2.3k 0.9×	2.6k 1.3×	1.0k 0.7×	663 1.8×	825 2.4×	115	4.3k
Sabina Chiaretti Italy	35	1.5k 0.6×	1.8k 0.9×	944 0.6×	716 2.0×	961 2.7×	130	4.1k
Bruno Paiva Spain	36	2.6k 1.1×	3.4k 1.7×	1.9k 1.3×	804 2.2×	829 2.4×	157	4.7k
Kolja Eppert Canada	16	1.8k 0.8×	985 0.5×	841 0.6×	605 1.7×	237 0.7×	27	3.1k
Karsten Spiekermann Germany	45	2.5k 1.0×	3.6k 1.9×	1.2k 0.8×	960 2.7×	1.3k 3.8×	178	5.5k
Max Chaffanet France	36	2.4k 1.0×	953 0.5×	1.5k 1.0×	377 1.0×	756 2.2×	105	4.4k
Norma C. Gutiérrez Spain	41	3.3k 1.4×	3.4k 1.8×	1.7k 1.2×	645 1.8×	1.2k 3.4×	179	5.6k

Countries citing papers authored by Erming Tian

Since Specialization

Citations

This map shows the geographic impact of Erming Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erming Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erming Tian more than expected).

Fields of papers citing papers by Erming Tian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erming Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erming Tian. The network helps show where Erming Tian may publish in the future.

Co-authorship network of co-authors of Erming Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Erming Tian. A scholar is included among the top collaborators of Erming Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erming Tian. Erming Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mohan, Meera, Zimu Gong, Cody Ashby, et al.. (2023). Concomitant deletion of the short arm (del(1p13.3)) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outcome in multiple myeloma. Cancer. 129(16). 2491–2498. 5 indexed citations

Mohan, Meera, Anikó Szabó, Sharmilan Thanendrarajan, et al.. (2021). Persistent bone marrow minimal residual disease as a “high‐risk” disease feature in multiple myeloma. American Journal of Hematology. 96(9). E341–E344. 2 indexed citations

Mohan, Meera, Samantha Kendrick, Anikó Szabó, et al.. (2021). Clinical implications of loss of bone marrow minimal residual disease negativity in multiple myeloma. Blood Advances. 6(3). 808–817. 18 indexed citations

Mohan, Meera, Manoj Kumar, Rohan Samant, et al.. (2021). Bone remineralization of lytic lesions in multiple myeloma – The Arkansas experience. Bone. 146. 115876–115876. 3 indexed citations

Binz, Regina Lichti, Erming Tian, Ratan Sadhukhan, et al.. (2019). Identification of novel breakpoints for locus- and region-specific translocations in 293 cells by molecular cytogenetics before and after irradiation. Scientific Reports. 9(1). 10554–10554. 19 indexed citations

Sawyer, Jeffrey R., Erming Tian, Brian A. Walker, et al.. (2019). An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q Syndrome. Blood Cancer Journal. 9(8). 62–62. 30 indexed citations

Tian, Erming. (2018). Fluorescence In Situ Hybridization (FISH) in Multiple Myeloma. Methods in molecular biology. 1792. 55–69. 3 indexed citations

Våtsveen, Thea Kristin, Anne‐Marit Sponaas, Erming Tian, et al.. (2016). Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro. Journal of Hematology & Oncology. 9(1). 75–75. 10 indexed citations

Sousa, Mirta Mittelstedt Leal de, Per Arne, Audun Hanssen‐Bauer, et al.. (2013). An Inverse Switch in DNA Base Excision and Strand Break Repair Contributes to Melphalan Resistance in Multiple Myeloma Cells. PLoS ONE. 8(2). e55493–e55493. 30 indexed citations

10.

Lamy, Laurence, Vu N. Ngo, N. C. Tolga Emre, et al.. (2013). Control of Autophagic Cell Death by Caspase-10 in Multiple Myeloma. Cancer Cell. 23(4). 435–449. 185 indexed citations

11.

Tian, Erming, Toril Holien, Randi Utne Holt, et al.. (2009). c‐Met signaling promotes IL‐6‐induced myeloma cell proliferation. European Journal Of Haematology. 82(4). 277–287. 40 indexed citations

12.

Santin, Alessandro D., Stefania Bellone, Luis E. De Las Casas, et al.. (2005). Determination of HER2/neu status in uterine serous papillary carcinoma: Comparative analysis of immunohistochemistry and fluorescence in situ hybridization. Gynecologic Oncology. 98(1). 24–30. 71 indexed citations

13.

Santin, Alessandro D., Fenghuang Zhan, Stefania Bellone, et al.. (2004). Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy. International Journal of Cancer. 112(1). 14–25. 253 indexed citations

14.

Sawyer, Jeffrey R., Guido Tricot, Janet L. Lukacs, et al.. (2004). Genomic instability in multiple myeloma: Evidence for jumping segmental duplications of chromosome arm 1q. Genes Chromosomes and Cancer. 42(1). 95–106. 84 indexed citations

15.

Tian, Jingyan, et al.. (2003). Cloning and sequence analysis of tumor-associated gene hMMTAG2 from human multiple myeloma cell line ARH-77.. PubMed. 35(2). 143–8. 2 indexed citations

16.

Tian, Erming, Fenghuang Zhan, Ronald C. Walker, et al.. (2003). The Role of the Wnt-Signaling Antagonist DKK1 in the Development of Osteolytic Lesions in Multiple Myeloma. New England Journal of Medicine. 349(26). 2483–2494. 1128 indexed citations breakdown →

17.

Shaughnessy, John D., Erming Tian, Jeffrey R. Sawyer, et al.. (2002). Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization‐defined chromosome 13 deletion in multiple myeloma: early results of total therapy II. British Journal of Haematology. 120(1). 44–52. 115 indexed citations

18.

Tian, Erming, Jeffrey R. Sawyer, David A. Largaespada, et al.. (2000). Evi27 encodes a novel membrane protein with homology to the IL17 receptor. Oncogene. 19(17). 2098–2109. 53 indexed citations

19.

Shaughnessy, John D., David A. Largaespada, Erming Tian, et al.. (1999). Mrvil, a common MRV integration site in BXH2 myeloid leukemias, encodes a protein with homology to a lymphoid-restricted membrane protein Jaw1. Oncogene. 18(12). 2069–2084. 39 indexed citations

20.

Santin, Alessandro D., Paul L. Hermonat, Antonella Ravaggi, et al.. (1998). Effects of retinoic acid combined with interferon‐gamma on the expression of major‐histocompatibility‐complex molecules and intercellular adhesion molecule‐1 in human cervical cancer. International Journal of Cancer. 75(2). 254–258. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact